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Coffee consumption is believed to have chemopreventive and chemotherapeutic effects and to contribute to preventing the
development and progression of cancer. However, there is still controversy around these claims. As indicated in our previous
works, diet can influence the risk of breast cancer. Intake of coffee is hypothesized to reduce this risk, but current scientific
evidence is not conclusive. This work is aimed at studying the effects of Robusta coffee bean extract on cell viability,
proliferation, and apoptosis of different human cancers, especially breast cancer cell lines. To this end, cell viability was
evaluated by Alamar Blue in 2D and 3D models, the cell cycle by PI, apoptosis by annexin V, mitochondrial morphology, and
functionality by mitoTracker, and colony formation capacity by the clonogenic assay. Green and dark coffee extract significantly
reduced viability in human breast, colorectal, brain, and bone cancer cells. Coffee anticancer activity was clearly evidenced in
MDA-MB-231 (ER-) and MCF-7 (ER+) breast cancer cells but not in the normal breast cell line. In addition, coffee extract
induces an increase S phase and a decrease G2/M population in breast cancer cells, affected the mitochondrial morphology, and
triggered apoptosis. MDA-MB-231 breast cancer cells lost their clonogenic capacity after treatment. The antitumor activity was
demonstrated in both 2D and 3D culture cell models.
1. Introduction
Cancer is currently a major public health problem, and the
available therapeutic strategies are not fully effective in sev-
eral tumor types. The American Cancer Society estimates
that by 2019, approximately 17,624,50 new cancer cases will
be diagnosed, which is equivalent to more than 4,800 new
cases every day [1] In addition, there will be approximately
268,600 new female breast carcinoma cases in the United
States [2]. Among the different cancer types, breast cancer
is one of the most frequently diagnosed and the leading cause
of cancer death in females worldwide.
Breast cancer etiology is considered multifactorial, and it
includes interactions between genetic, behavioral, and envi-
ronmental factors. Breast cancer is a heterogeneous disease,
but cancer subtypes are hormone-related. Breast tumors that
express the ER (ER+ tumors) are more strongly associated
with hormone-related factors than tumors that do not
express the ER (ER− tumors).
According to an analysis that verified the antitumor
molecules approved by drug entities, such as FDA and simi-
lar organizations, 49% of anticancer molecules approved
between 1940 and 2014 were natural products or chemical
derivatives worldwide [3]. To understand the action of
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promising molecules in cancer treatment, it is necessary to
characterize active chemical components and study plants
in vitro and animals before clinical studies are conducted.
Phytochemicals, due to their dietary origin, are considered
safe, well-tolerated, and low-toxicity compounds, enabling
the synthesis of semisynthetic medicinal agents [4].
As stated in previous work, the diet may influence breast
cancer risk. Coffee intake has been hypothesized to reduce
the risk of breast cancer, but the current evidence is inconclu-
sive [5, 6]. Coffee is the second most popular beverage in the
world after water, and due to its low cost and ease of prepa-
ration, it is consumed in almost all countries and by all social
classes of the population through different preparation
modes. Coffee is a complex beverage that contains hundreds
of biologically active compounds and exerts potent effects on
long-term human health. A large number of recent studies
have focused on health outcomes associated with coffee
intake [7].
This drink contains caffeine, chlorogenic acid (CGA)
(which is caffeic bound to quinic acid), p-coumaroylquinic,
and feruloylquinic acids [8]. Although these acids are widely
present in beverages made from herbs, fruits, and vegetables,
consumption of these drinks represents only 5-10% of coffee
consumption. Coffee roasting is an important step during
coffee preparation, which improves its sensory properties.
In a previous study, we analyzed the coffee compounds pres-
ent in the extracts and observed that the roast process led to a
significant reduction in all of them [9]. This could be
explained by both amino acids and reducing sugars acting
as a substrate in the Maillard reaction. In the roast, CGAs
are hydrolyzed and new products, such as lactones, are
formed, and this process changes the antioxidant profile of
green coffee [10]. Moon et al. [11] reported that up to 99%
of CGA can be lost with the highest roasting [11].
Green coffee consumption as a dietary supplement or as a
beverage is increasing due to its reported antioxidant bene-
fits. Furthermore, the chemopreventive and anticancer
potential of bioactive molecules present in a standard cup
of coffee has been described not only in green coffee but also
in the beverage made from coffee, the black coffee. Indeed,
many retrospective meta-analysis and several human studies
have shown the benefits of coffee consumption for reduced
the incidence and risk of breast cancer (without showing
possible mechanisms) ([12–16], Vatten and Løken 1990,
[17–20]), while some in vitro studies have shown that coffee
induces antiproliferative effects in breast cancer cells MDA-
MB-231 [21]. Despite the information available, more
research is needed to understand the benefits of coffee. The
aim of this study was to investigate this knowledge gap,
analyzing the effect of Robusta coffee bean extracts obtained
by freeze-drying after different roasting processes and their
anticancerogenic effects both in 2D and 3D models on breast
carcinoma cell lines.
2. Materials and Methods
2.1. Coffee Samples. The coffee used in this study was Coffea
canephora. The green coffee beans were purchased from cof-
fee producers in Colatina-Espírito Santo, Brazil. The coffee
bags were transported to Rio de Janeiro and stored at the
Laboratory of Molecular Diagnostics and Mycology and then
processed in EMBRAPA Food Technology, Rio de Janeiro,
Brazil. Green coffee beans were selected after the elimination
of dirt and defective beans. Part of the green grains was
milled in an analytical grinder (IKA®A11 basic) to produce
the green coffee solution, and the remaining beans were
roasted in a grain roaster (Gene Café®). Dark roast was per-
formed at 245°C for 15min followed by Agtron scale. Then,
they were milled in a homemade grinder (Cuisinart®) and
an analytical grinder (IKA®A11 basic). Coffee powders were
sieved through an analytical sieve (710μm). The extracts at
50% w/v were prepared in hot water (90-95°C) for 10min.
To optimize the extraction procedure, ultrasound with sono-
trode (Hielscher®UIP1000hdT) and an ice bath (216 to 60W;
A = 70% for 10min) were performed. Then, the solutions
were centrifuged at 5643 RCF/5min (Rotina 38R–Hettich
zentrifugen), and the supernatant was dried in a freeze-
drier (dehydration at 60°C; air velocity of 1m/s for 32h).
The dehydrated extracts were stored in vacuum-laminated
zip-type packages at -80°C until analysis. Each 300mL of
50% coffee solution yielded 30 g of dry extract.
2.2. Cell Culture and Treatment Protocol. Human breast car-
cinoma (MCF7 and MDA-MB-231), human breast (MCF
10A), human bone carcinoma (U2OS), human colorectal
carcinoma (HCT116), and human brain glioblastoma multi-
form (T98G) cell lines were obtained from the ATCC-
Bethesda, MD, USA. Cell lines were plated and maintained
routinely in Dulbecco’s Modified Eagle’s Medium high glu-
cose (DMEM) supplemented with 10% fetal bovine serum
(FBS) plus antibiotics (100U/mL penicillin/0.1mg/mL strep-
tomycin), and pH7.4, under 5% CO2. Culture medium for
MCF 10A cell line was supplemented with 20 ng/mL epider-
mal growth factor, 100 ng/mL cholera toxin, 0.01mg/mL
human insulin, and 500ng/mL hydrocortisone. Once the
cells reached 80% confluence, they were dissociated using
0.05% trypsin-EDTA and subcultured. Culture medium was
replaced every 2 days. Cells were seeded in 96-well plates,
and after 24 h, the medium was changed to fresh supple-
mented DMEM medium. Cells were treated for 24 h with
increasing concentrations of green or dark coffee extracts dis-
solved in supplemented DMEM (25 to 5000μg/mL).
Untreated cells were included in each plate. Subsequently, a
cell proliferation assay was performed.
2.3. Cell Viability Assay. Cell lines were plated in 96-wells
plates and cultured for 24 h. Then, cells were treated for
24 h, and the culture medium replaced with alamarBlue®
10% v/v dissolved in DMEM supplemented with 10% FBS
and antibiotics. Three hours later, fluorescence (590 nm)
was monitored using a Biotek microplate reader, as recom-
mended by the manufacturer.
2.4. Cell Cycle Analysis. After treatment, cells were rinsed
briefly with phosphate buffered saline (PBS) and detached
using trypsin at room temperature. After centrifugation, the
cells were washed twice with PBS, resuspended in cold 70%
v/v ethanol solution, incubated for 24 h at 4°C, and treated
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with RNAse (200μg/mL) for 30min at 37°C. Then, the cells
were stained using propidium iodide (PI) (50μg/mL). The
cell suspension was analyzed for DNA content by flow
cytometry using a Beckton Dickinson FACSCanto II flow
cytometer. The relative proportions of cells with DNA
content indicative of apoptosis (<2n), G0/G1 diploid (2n), S
(phase > 2n but < 4n), and G2/M phase (4n) were deter-
mined using FlowJo V10 software (10.7.1). Cell cycle anal-
yses were performed by the Watson Pragmatic algorithm
model. Nuclei of viable cells were gated according to the
SCC-H×FL2-H ratio [22].
2.5. Apoptosis Analysis. To measure the apoptosis rate, the
cells were stained using FITC-conjugated Annexin V and
PI. The nonadherent cells were collected, and the adherent
cells were quickly washed with PBS and detached using tryp-
sin/EDTA 0.125% (Sigma chemical Co., St. Louis, USA) at
room temperature. Subsequently, cells were stained with
Annexin V-FITC/propidium iodide (PI) (BD Pharmingen,
New Jersey, USA) according to the manufacturer’s instruc-
tions, quantified by flow cytometer using a Beckton Dick-
inson FACSCanto II and analyzed using FlowJo V10
software [9].
2.6. Colony-Forming Units. Exponentially growing MDA-
MB-231 and MCF 10A cells were harvested, counted, and
seeded (1.106 cells/plate) in Petri dishes. Cells were allowed
to grow at 37°C in 5% CO2 overnight. Then, cells were incu-
bated with different coffee concentrations for 24 h. Next, the
cells were harvested, counted, and reseeded at low density
(about 50-250 cell/well) in 24 multiwell plates (Corning
Costar USA). After incubation for additional 15 days, the col-
onies were stained with crystal violet 5% v/v solution for
20min. The number of clones (colonies > 50 cells) in a given
area was counted for each condition [23].
MCF7 is a breast ductal carcinoma cell line that corre-
sponds to a relatively less aggressive hormone-responsive
breast cancer (better prognosis). MCF-7 cells express lower
levels of VEGF than MDA-MB-231 cells, which have high
invasive and migration capacities. Due to this, we believe that
MCF7 cell lines were not suitable for the colony formation
assay [24, 25].
2.7. Mitochondrial Morphology. MDA-MB-231, MCF7, and
MCF 10A cells were grown on 12mm glass coverslips and
treated using coffee extracts (0 and 1000μg/mL) for 24h.
Next, cells were incubated with 100nM MitoTracker Red
CMXRos (Invitrogen M7512), dissolved in DMEM, for
30min at 37°C and washed twice with PBS [26]. The cells
were then fixed using 4% paraformaldehyde solution for
15min at room temperature, washed twice with PBS, and
mounted using Fluorsafe (Calbiochem). Images were
collected using a confocal microscope Olympus FV1200
(Super-corrected 60X objective–plapon 60XOSC).
2.8. Mitochondrial Functionality (MMP). MDA-MB-231,
MCF7, andMCF 10A cells were grown on 24multiwell plates
for 48h and treated using coffee extracts (5000 and
1000μg/mL) for 4 and 24 h. Next, cells were collected by
trypsinization and incubated with 100 nM MitoTracker Red
CMXRos (Invitrogen M7512) for 30min and then analyzed
by flow cytometry in a Forteza cytometer. The frequency his-
togram analysis was performed using FlowJo V10 software.
2.9. Spheroid Generation. The spheres were formed from cells
using the hanging drop system: Perfecta3D® 96-well plates
(3D Biomatrix; Michigan, USES) 6 × 103 for MDA-MB-231
or MCF 10A and suspended on the lid of a Petri dish for
MCF7. Partial medium exchange was made every two days.
After incubation of the MDA-MB-231 cell line for 7 days,
MCF7 cell line for 6 days, and MCF 10A cell line for 4 days,
the spheroids were treated with coffee extracts at the
desired concentration for 24 h. After treatment, the spheres
were observed using a Leica microscope and then incu-
bated with alamarBlue ® 10% v/v in DMEM supplemented
with 10% FBS and antibiotics for 24h. The plate was read
using the Biotek plate reader to measure the fluorescence
at 590nm [27].
2.10. Statistical Analysis. Results are expressed as mean
values and the corresponding standard deviation of experi-
ments done in triplicate. The data were analyzed with the
statistical software GraphPad Prism (version 8.0, GraphPad
software, San Diego, CA). The significant differences are
indicated by letters as determined by one-way analysis of
variance (ANOVA) followed by Tukey’s posttest (p < 0:05).
3. Results and Discussion
The coffee extracts used in this study were obtained by stan-
dardized processes by the Brazilian national company of
“Pesquisa Agropecuária” from green Coffea canephora beans
acquired from coffee producers in Colatina-Espírito Santo,
Brazil. They were carefully selected, transported, ground,
roasted, sieved, lyophilized, and fried using standardized
times and temperatures to ensure reproducible results.
Robusta green and roasted coffee extracts made in this study
were obtained as close as possible to the typical preparation
of a coffee for consumption (See Section 2 for further
information).
Experiments were carried out to evaluate the effects of
coffee extracts on cancer cells. For this purpose, cell viability
was analyzed after incubation with different concentrations
of coffee extracts dissolved in DMEM medium for 24 h. As
observed in Figures 1(a) and 1(b), human cancer cell line
viability (breast carcinoma) was significantly decreased in a
concentration-dependent manner. Surprisingly, a compa-
rable effect was observed in cancer lines from colon
(CHT116), brain (T98G), and bone (U2OS) (Supplementary
Figure 1A-C). Our data show that both green and dark coffee
extracts inhibited the proliferation of MCF7 (ER+) and
MDA-MB-231 (ER-) human breast cancer cell lines
(Figures 1(a) and 1(b)). However, cell viability was not
affected in the breast nontumorigenic MCF 10A cell line
except at high concentration (log 3 μg/mL = 1000 μg/mL)
(Figure 1(c)). Several coffee constituents may differentially
affect ER+ and ER- breast cancer subtypes. Rosendahl et al.
[28] showed that caffeine doses significantly inhibited the
proliferation and total cell number of both ER+ MCF7 and












































































Figure 1: Coffee extract effect on cell cancer viability. Human cancer cell lines (MCF7 and MDA-MB-231) and human epithelial breast cell
lines (MCF 10A) were treated for 24 h with increasing concentrations of (a) green coffee or (b) dark coffee (0-5000μg/mL). (c) Inhibitory
concentration 50% (IC50) on breast cell line treated with green and dark coffee was determined and expressed as μg/mL. ∗ represents
statistically significant difference in the column indicated with respect to treated MCF 10A, as determined by ANOVA (p < 0:05), with
Tukey’s multiple comparison posttest. (d) Cell morphology was analyzed by light microscopy. Scale bar = 50 μm. Values are represented as
mean ± SEM from three independent experiments.
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ER- MDA-MB-231 breast cancer cells, with a maximum
inhibition at 5mmol/L. However, caffeine alone is not able
to match the effects of coffee [28].
The chemical composition of coffee varies because the
preparation process may change the content of bioactive
compounds, resulting in different types of coffee beverages
around the world, as widely reported in the literature. During
roasting, the chlorogenic acid content decreases, while mela-
noidins are formed as complexes of sugars, amino acids, and
chlorogenic acid through the Maillard reaction, or vitamin B
niacin from the trigonelline alkaloid. Instant coffee or a paper
filter on the coffee beans leads to almost complete removal of
the diterpenes of cafestol and kahweol. The caffeine content
varies according to the type of coffee and can also be modi-
fied by the preparation process [29]. Recent studies have
described the presence of phytochemicals with proven bioac-
tive effects in coffee, such as caffeine, polyphenols, trigonel-
line, caffeic acid, melanoidins, acid nicotinic, flavonoids,
CGAs, kahweol, and cafestol [30–32] and the health benefits
of these compounds. Nevertheless, the mechanisms responsi-
ble for the chemopreventive coffee effects continue to be
studied for a better understanding. Various health benefits
of coffee have recently been studied, with special emphasis
on its protective effect against DNA damage. Our previous
publication demonstrated that coffee has an important activ-
ity and antioxidant capacities in prostate cell cancer, decreas-
ing the cell proliferation and inducing programmed death in
apoptosis [9]. Therefore, coffee can be used as a chemopre-
ventive and chemotherapeutic agent that contributes to pre-
venting cancer development and progression [30, 31, 33, 34].
The bioactive components of coffee on the human body affect
the endogenous antioxidant and detoxification processes
[35]. In addition, coffee has a suppressive effect on the proin-
flammatory signaling pathway and on the carcinogenesis
process itself. The coffee components interfere with all carci-
nogenesis phases: initiation, progression, and metastasis [29].
Caffeine and the polyphenol content have been suggested
to contribute to coffee anticancer activities. Dried green cof-
fee beans contain carbohydrates (59–62%), CGAs (7–10%),
aliphatic acids (2%), caffeine (1–2%), trigonelline (1%), and
free amino acids (<1%), but roasting coffee reduces the con-
tents of carbohydrates, CGAs, and free amino acids and
increases those of alkaloids (mostly caffeine) and aliphatic
acids [36]. Although, theoretically, the bioactive compound
content is lower in roasted coffee, due to the high-
temperature process, we tested cell viability after treatment
with dark roasted coffee extracts, since the consumption of
roasted coffee is greater in the diet. Although both types of
coffee showed a significant antitumor effect on both MDA-
MB-231 (ER-) and MCF7 (ER+) breast cancer cell lines, the
green coffee extract showed a lower cytotoxic effect on
MCF 10A cells (compared to dark coffee), and therefore, it
was selected to continue the studies.
To investigate the effects on cell morphology, breast cancer
cell lines were incubated with green coffee extracts at concen-
trations of 500 and 1000μg/mL for 24h. As shown in Figure 1,
MDA-MB-231 and MCF7 cell morphology was significantly
altered showing rounded cells, which indicates cell detach-
ment and death. Besides, green coffee decreased cell density
but did not alter cell density and morphology in MCF 10A
cells (Figure 1(d)). STS was used as a positive control of apo-
ptotic damage (a well-known apoptotic inducer) [37].
The results of the cell cycle analysis indicate that the
treatment of cells with green coffee extract at 1000μg/mL
led to an increase S-phase and a decrease G2/M population
of the cell cycle in both breast cancer cell lines (MDA-MB-
231 and MCF7). In contrast, it was not observed modifica-
tions in the cell cycle population distribution of MCF 10A
normal breast cell line, with the same treated (Figures 2(a)
and 2(b)). No previous work has described the effects of cof-
fee extract on cell cycle arrest in ER- breast cancer cell lines.
Our results show that cell incubation with coffee extracts
induces cell death. Consequently, we next evaluated cell
death type triggered by nuclear fragmentation analysis. After
treatment, cells were stained using Höechst 33342, and
nuclear morphology was analyzed by fluorescent micros-
copy. A chromatin condensation distinctive pattern and
nuclear fragmentation (apoptotic bodies) were observed in
the MDA-MB-231 and MCF7 cells treated, but not in MCF
10A cells (Figure 2(c)). Next, we also analyzed cell death type
triggered by green coffee extracts using propidium iodi-
de/Annexin V stain by a cytometric assay. Figures 3(a) and
3(b) show the percentage of apoptosis induction by coffee
extracts, in MCF7 and MDA-MB-231 breast cancer cell lines
(60 and 15% induction, respectively). In contrast, coffee
extract had no apoptotic effect on MCF10A breast nontumor
cell lines, showing less of 8% apoptotic cells.
The antitumor effect of coffee is thought to be based on
several mechanisms. The antioxidant effect is conditioned
not only by the content of direct antioxidants but also by
the ability to activate endogenous antioxidant enzymes like
superoxide dismutase (SOD) and γ-glutamylcysteine synthe-
tase [38, 39]. At present, substantial experimental evidence
shows that it is possible to prevent mitochondrial damage
by protecting against oxidative stress [40]. Furthermore,
mitochondrial oxidative stress plays a key role in apoptosis
[41]. In different cell types, mitochondrial fragmentation
induced by oxidative stress has been reported [42, 43]. Addi-
tionally, the process of apoptosis initiation is associated with
mitochondrial fragmentation and the release of proapoptotic
proteins [44, 45]. Therefore, we examined the effects of green
coffee extracts on mitochondrial morphology in MDA-MB-
231, MCF7, and MCF 10A cells.
Mitochondria are critical organelles that ensure the nor-
mal function of the cells. These organelles play a crucial role
in generating cellular energy and regulating cell fate through
their participation in cell-death regulation [46]. Mitochon-
dria morphology was analyzed using the mitochondrion-
selective probe Mitotracker Red CMXRos, and, as illustrated
in Figure 4, green coffee extracts induced important changes
and fragmentation in MDA-MB-231 and MCF7 mitochon-
dria, observed as dotted (3rd column). Normal mitochondrial
morphology (as observed in control cells, 1st column) was
altered after 4 h of treatment with green coffee, while MCF
10A cells maintained their morphology intact.
Since changes in mitochondrial membrane potential
(MMP) are associated with cell death and given the results
of the microscopy analysis (Figure 4), in which we observed
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a considerable change in mitochondrial morphology related
to the incubation with coffee extracts, we analyzed the
MMP using MitoTracker Red CMXRos stain and flow
cytometry. The accumulation of this probe depends on the
MMP, and therefore, a diminution in its accumulation is
associated with changes in the MMP [47]. To evaluate this
process, MCF10 A, MCF7, and MDA-231 cells were incu-
bated for 4 and 24 h in the presence of 500 or 1000μg/mL
of coffee extracts. Cells were then collected by trypsinization,
stained using MitoTracker Red CMXRos, and then analyzed
by flow cytometry. As shown in Figure 5, the incubation of
cells with the extract for 4 or 24 h triggered a significant
reduction in the probe accumulation compared to that
observed in control (show as a shift of the peak towards the
left side, with respect to the control of each cell line). This
reduction in probe accumulation, related to MMP changes,
was observed in both malignant breast cancer cell lines, but
not in MCF10 A, in which the MMP sensitive probe accumu-
lated similarly in the presence or absence of coffee extracts.
In agreement with our results, several studies proposed
that caffeine treatment significantly suppressed cell growth
and viability and induced apoptosis by activating the caspase
pathway in gastric cancer cells [48], epidermal cells [49], and
glioma cells [50]. Also, Furtado et al. noted that coffee and
caffeine protect the liver from thioacetamide-induced injury
in rats by reducing cleaved caspase-3 labeling indexes and
growth fraction [51]. Caspase-3 is involved in apoptosis
induction. It mediates the proteolytic cleavage of key pro-
teins, such as the nuclear PARP, which plays a role in chro-
matin condensation and degradation in apoptotic cells [52].
However, the function of caspase-3 in the pathway of
coffee-induced apoptosis is not clear [49]. It was observed
that the treatment with coffee extracts induces activation of
caspase-3 in MDA-231-MB cell line (Supplementary
Figure 1D-E) suggesting that apoptosis signaling mediated
by coffee extract triggered cell death and involves the
cleavage of this cysteine protease.
To further investigate the effect of coffee on breast cancer
cells, we conducted a colony formation assay (in vitro cell
survival assay, based on the single-cell ability to grow in a col-
ony). This assay allowed us to determine the cell clonogenic
capacity after exposure to cytotoxic agents [53]. The results
showed that green coffee extracts significantly inhibited the
number of colonies formed by MDA-MB-231 cells after
treatment, relative to untreated cells, thus acting as a cyto-
toxic and/or cytostatic agent. Additionally, we observed that
the treatment did not affect MCF 10A cells’ clonogenic
capacity (Figure 6). Although the assay was repeated by
increasing the number of cells to 500/well, MCF7 was unable
to form colonies under controlled conditions. Due to their
ability to grow into domes, MCF7 cells were not suitable for
the colony formation assay [24, 25].
Our results are similar to those found in prostate tumor
cells (DU-145) treated with coffee CGAs, which showed a
















Figure 2: Coffee extract effect on cell morphology and cell cycle progression. MCF 10A, MDA-MB-231, and MCF7 cells were treated during
24 h with green coffee extract at 0 (control), 500, or 1000 μg/mL. (a) DNA content profiles using propidium iodide stain to compare the cell
cycle progression. (b) Quantification of cell population proportion in different cell cycle phases. Values represent themean ± SEM from three
independent experiments. Cell cycle were determined using FlowJo V10 software (10.7.1) and analyzed by the Watson Pragmatic algorithm
model. Each concentration of coffee extract used was compared with its respective cell line control (∗p < 0:005; ∗∗p < 0:001; ∗∗∗p = 0:0001) as
determined by ANOVA, with Tukey’s multiple comparison posttest. (c) Nuclear fragmentation was analyzed using Höestch 33342 staining.
Staurosporine (STS) was used as a positive control for nuclear fragmentation. The white arrows indicate fragmented nuclei. Scale bar = 50μm.





















































































































































































































Alive (Annexin − PI−)
Early apoptosis (Annexin + PI −)
Late apoptosis (Annexin + PI +)
Necrosis (Annexin − PI +)
(b)
Figure 3: Apoptosis induction by green coffee extract. MCF 10A, MDA-MB-231, and MCF7 cells were treated for 24 h with green coffee at 0,
500, or 1000μg/mL. (a) Apoptosis flow cytometry analysis by Annexin V/propidium iodide staining was performed, and representative plots
are presented. (b) Quantification of apoptosis induction (relative to control). Values are mean ± SEM from three independent experiments
(∗∗∗p < 0:0001) as determined by ANOVA, with Tukey’s multiple comparison posttest.
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reduced colony formation capacity after treatment [54].
Besides, anchorage studies showed that CGAs can form sta-
ble complexes with protein kinase and induce this protein
translocation from cytosol to the plasma membrane, trigger-
ing cell death via disruption of mitochondria [55]. It was
observed that 5-CQA in breast cancer cell line MDA-MB-
231 (a CGAs: 5-O-caffeoylquinic acid) can modulate the
activity of Ras proteins by inhibition upon binding to the tar-
get [56]. Further research is needed to elucidate the molecu-
lar basis of the activity of natural extracts of green and



































Figure 4: Green coffee effect on mitochondrial morphology. MDA-MB-231, MCF7, and MCF 10A cells were treated for 0, 2, and 4 h with
green coffee extracts at 1000μg/mL or STS 6 nM for 4 h. Representative microphotographs show the mitochondrial (green-MitoTracker
Red CMXRos) and nuclear (blue-DAPI) stain. Scale bar = 50 μm (upper row), zoom scale bar = 10μm (lower row).
9Oxidative Medicine and Cellular Longevity























































































































































































103 104 1050−103 103 104 1050
−103 103 104 1050












































































Figure 5: Green coffee effect on mitochondrial membrane potential. MDA-MB-231, MCF7, andMCF 10A cells were treated for 0, 4, and 24 h
with green coffee extracts at 500 and 1000 μg/mL. Cells were collected and incubated with 100 nMMitoTracker Red CMXRos for 30min and
then analyzed by flow cytometry. Representative histograms of each treatment are presented.
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In addition, we investigated the therapeutic potential of
green coffee extract on a 3D cell culture model, generating
spheroids from MCF 10A, MCF7, and MDA-MB-231 cells.
On days 4, 6, or 7 of culture, respectively, these spheroids
were treated with different concentrations of green coffee
extracts for 24h and then analyzed by microscopy. MDA-
MB-231 and MCF 10A spheroid morphology was not modi-
fied by the treatment, but MCF7 spheroids lost their cellular
compaction level until forming very lax aggregates
(Figure 7(a)). A significant decrease in cellular viability of
MDA-MB-231 and MCF7 spheroids was observed. Despite
this strong anticancer effect, the viability of MCF 10A did
not show alterations (Figure 7). As previously reported
[57], we observed that spheroids were resistant to a higher
cytotoxic agent concentration in comparison with cells
grown in monolayers.
The ability of dietary substances to modulate the immune
response and suppress the proinflammatory environment in
the body is considered to be one of the important mecha-
nisms of tumor chemoprevention [35]. In humans, after food
consumption, the level of each nutraceutical in the blood
plasma varies, making it even more difficult to attribute the
possible anticancer effects of coffee to a specific molecule.
In fact, only a small percentage of the ingested compounds
enter the circulatory system and reach tissues, and very little
of the absorbed material retains the original structure
present in the beverage [31]. In this work, the treatment of
1000μg/mL coffee extract is equivalent to 0.001 g coffee dry
extract (powder), which represents 0.05mL of coffee ready
to drink in a 10% solution (this is a common concentration
of daily coffee consumption). Several constituent compounds
of coffee have important antioxidant activities. Ingredients
other than caffeine, such as CGAs and caffeic acid, are
antioxidant in nature, and their presence slows down the
inflammation process, thereby providing protection from
the hazardous effect of free radicals and from endothelial
damage. In fact, coffee intensifies the antioxidant defense
mechanism of the immune system by inducing the expres-
sion of mRNA and enzymes mitigating the negative effects
of free radicals on neurodegeneration [30]. Caffeine has been
positioned as a protective agent for cell membranes against
oxidative damage, with anticancer activity [33], and CGAs
(the most important class of polyphenols) are well known
as powerful antioxidants [31, 34].
In previous work, the antioxidant activity of extracts with
different degrees of roasting was analyzed. We demonstrated,
through several tests, that Robusta green coffee and lightly
roasted extracts had a higher antioxidant potential [9]. In this
work, we document the stimulation of mitochondrial fragmen-
tation by coffee in breast cancer cells, possibly induced by oxi-
dative stress, which was not observed in noncancer breast cells.
A reduction or even elimination of coffee consumption
has been traditionally recommended in view of a global
risk profile, but its consumption has progressively been
considered in a less negative light due to its better-

















































Figure 6: Green coffee effect onMDA-MB-231 andMCF 10A cell clonogenic capacity. Cells were treated for 24 h with green coffee extracts at
0, 500, and 1000 μg/mL. Then, the surviving cells were seeded at low density for a clonogenic assay. (a) Representative results are shown for
each condition stained with crystal violet. Scale bar = 0:5 cm. (b) Quantification of the viable clones. Values are the mean ± SEM of three
independent experiments (∗∗∗p = 0:0001 with respect to control and ^^p < 0:001) between cases as determined by ANOVA, with Tukey’s
multiple comparison posttest.
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and caffeine are not equivalent has increased the interest
in determining whether other components of coffee might
contribute to the protective action in the human body.
Coffee is a complex beverage containing more than 1000
described phytochemicals responsible for its pleasant flavor,
aroma, and health promoters. Several recent scientific publi-
cations have described beneficial coffee effects and discussed
potential mechanisms of action, including anti-inflammatory
[59, 60], antiamyloidogenic [61], antimicrobial, antiglycative
[62], hepatoprotective, antidiabetic, and antiosteoclastogenic
effects [63, 64].
Recent epidemiological and prospective (meta-analy-
sis) studies demonstrate that consumption of healthy
foods, such as coffee, especially rich in polyphenol con-
tent, might have antitumor activity against several can-
cer types, such as colorectal [65], nonmelanoma [66],










































Figure 7: Green coffee extract effect on a 3D model of spheroids. 6 × 103 MDA-MB-231, MCF7, or MCF 10A cells were seeded (40 μL)
and cultured for 7, 6, and 4 days, respectively. Spheroids were treated with green coffee extracts at 0, 2000, 3000, 3500, and 4000 μg/mL
for 24 h. (a) Representative microphotographs showing spheroid morphology are presented. Scale bar = 100μm. (b) Spheroids viability
was analyzed for the AlamarBlue ® assay and quantified. Values are the mean ± SEM from three independent experiments
(∗p < 0:005; ∗∗p < 0:001; ∗∗∗p = 0:0001) between cases as determined by ANOVA, with Tukey’s multiple comparison posttest.
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Especially in reference to breast cancer, numerous
authors provided evidence on a strong and significant inverse
association between cancer risk and coffee consumption [16],
including carrying the BRCA1mutation subgroup of patients
[72], with ER- tumors [13, 14], tamoxifen-treated with ER+
tumors [15], and postmenopausal tumors [12]. Some studies
have shown that women who consume regular coffee had 20
to 50% reduction in the incidence of breast cancer [19, 73].
Other authors report the metastasis decrease [18, 20] and
breast cancer cell apoptosis induction. These observations
are in line with the results reported by Amigo-Benavent
et al. [21].
4. Conclusion
In the present work, we showed that coffee extracts have anti-
proliferative and cytotoxic effects on breast cancer cells in 2D
and 3D culture models. Surprisingly, coffee extracts do not
affect viability on human epithelial breast cell lines (noncar-
cinogens). Our results suggest that green and roasted coffee
bean extracts showed a strong bioactive capacity, promoting
cell viability decrease, cell cycle alteration, cytostatic effect,
mitochondrial morphology, andMMP alterations and clono-
genic capacity loss.
These extracts of Coffea canephora have been charac-
terized in a previous work, in which we found a total
phenolic compounds with values of 2198:7 ± 71:0 (dark
roasted freeze-dried) or 3051:1 ± 33:7mg gallic acid
equivalents/100 g (green freeze-dried) and a caffeine con-
tent between 0.1 and 0.3 g/100 g, respectively [9]. Although
greater knowledge about the chemical composition of
coffee extracts could help to understand the possible
compounds responsible for the observed effect, many
authors have investigated the effect of isolated com-
pounds (caffeine, phenolic compounds, trigonelline, fla-
vonoids, chlorogenic acid, caffeic acid, etc.), but could
not attribute to a single compound in the bioactive
properties of the complex mixture obtained when pre-
paring coffee, because they use different extracts to those
of a typical coffee prepared, or they enhance the extrac-
tion of bioactive compounds [10, 28, 30].
The results presented herein have far-reaching health rel-
evance since coffee compounds could be used as chemopre-
ventive and chemotherapeutic medicine which, in addition
to their antioxidant activities and capacities, can also provide
nutrition and contribute to preventing cancer development
and progression. As suggested by other authors, a cancer
diagnosis could be a stimulus for patients to make protective
changes in health, and health professionals should consider
this as a window of opportunity to educate patients about a
healthy lifestyle [74]. Further, before these encouraging epi-
demiological observations can be confirmed and used as a
sound basis for dietary advice, further research is needed on
the bioavailability and pharmacokinetics of coffee [31]. In
our experiments, we treated cells with concentrations equiv-
alent to one cup of coffee (50mL). However, we cannot
immediately extrapolate these results to humans without
considering the individual human metabolism, and further
research (as in vivo experiments) is necessary to reach this
conclusion.
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